| Public Notice | Monitoring | N/A | N/A | Jul 5, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 5, 2025 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.011 | Mar 31, 2025 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Mar 31, 2025 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Mar 31, 2025 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Resolved | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Resolved | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Resolved | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Resolved | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Resolved | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Resolved | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Resolved | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 30, 2024 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 30, 2024 | Active | N/A |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Combined Uranium | Health-Based | N/A | 49 | Sep 30, 2024 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 50 | Jun 30, 2024 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 50 | Jun 30, 2024 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 50 | Jun 30, 2024 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 50 | Jun 30, 2024 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.011 | Jun 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Jun 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Jun 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Jun 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Public Notice | Monitoring | N/A | N/A | Jun 26, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 26, 2024 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.011 | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Combined Uranium | Health-Based | N/A | 49 | Mar 31, 2024 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 49 | Mar 31, 2024 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 49 | Mar 31, 2024 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 49 | Mar 31, 2024 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.013 | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Combined Uranium | Health-Based | N/A | 48 | Dec 31, 2023 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 48 | Dec 31, 2023 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 48 | Dec 31, 2023 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 48 | Dec 31, 2023 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.014 | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.014 | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.014 | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.014 | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Combined Uranium | Health-Based | N/A | 50 | Jun 30, 2023 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 50 | Jun 30, 2023 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 50 | Jun 30, 2023 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 50 | Jun 30, 2023 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.012 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Combined Uranium | Health-Based | N/A | 49 | Mar 31, 2023 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 49 | Mar 31, 2023 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 49 | Mar 31, 2023 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 49 | Mar 31, 2023 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.012 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Combined Uranium | Health-Based | N/A | 49 | Dec 31, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 49 | Dec 31, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 49 | Dec 31, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 49 | Dec 31, 2022 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.012 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Combined Uranium | Health-Based | N/A | 50 | Sep 30, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 50 | Sep 30, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 50 | Sep 30, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 50 | Sep 30, 2022 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.012 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Combined Uranium | Health-Based | N/A | 47 | Jun 30, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 47 | Jun 30, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 47 | Jun 30, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 47 | Jun 30, 2022 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.012 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Public Notice | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 48 | Mar 31, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 48 | Mar 31, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 48 | Mar 31, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 48 | Mar 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 49 | Dec 31, 2021 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 49 | Dec 31, 2021 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 49 | Dec 31, 2021 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 49 | Dec 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 27, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 27, 2021 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 46 | Sep 30, 2021 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 46 | Sep 30, 2021 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 46 | Sep 30, 2021 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 46 | Sep 30, 2021 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 47 | Jun 30, 2021 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 47 | Jun 30, 2021 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 47 | Jun 30, 2021 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 47 | Jun 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 28, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 28, 2021 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 46 | Mar 31, 2021 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 46 | Mar 31, 2021 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 46 | Mar 31, 2021 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 46 | Mar 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 28, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 28, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2021 | Resolved | N/A |